# POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

Study · id `cardio:ct-nct07469722` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07469722](<https://clinicaltrials.gov/study/NCT07469722>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07469722

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 128 participants.

## Technical summary

Registry record NCT07469722. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (anticipated); primary completion 2028-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 128 participants (planned count; ClinicalTrials.gov record NCT07469722, source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)
- Planned start: 2026-03-23 (anticipated) (ClinicalTrials.gov record NCT07469722, source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)
- Primary completion: 2028-01-31 (anticipated) (ClinicalTrials.gov record NCT07469722, source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT07469722, source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT07469722, source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07469722-2026-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
- Acronym: POINTER-HF
- Condition: Acute Heart Failure (AHF)
- Condition: Congestive Heart Failure Acute
- Condition: Diuretic Effect
- Condition: Lung Ultrasonography Score
- Condition: Ultrasonography, Doppler
- Condition: Point-of-care Ultrasound (POCUS)
- Intervention (Drug): Furosemide 40 Milligrams.
- Intervention (Drug): Furosemide 40 Milligrams.
- Intervention (Drug): Hydrochlorothiazide (HCTZ) 25 milligrams.
- Intervention (Drug): Acetazolamide 250 milligrams.
- Intervention (Drug): Dapagliflozin (10mg Tab)
- Intervention (Drug): Potassium Chloride Oral Product
- Lead sponsor: Hospital de Clinicas de Porto Alegre
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Hospital de Clinicas de Porto Alegre (`cardio:org-hospital-de-clinicas-de-porto-alegre`)

## Provenance

Content hash: 6a70acb62405f563de4d53fd520e00fa590f4fa574157873d5fc83004870f188
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
